Overview

An Open-Label Extension of BPS-MR-PAH-201 in Pulmonary Arterial Hypertension (PAH) Patients

Status:
Completed
Trial end date:
2013-11-30
Target enrollment:
Participant gender:
Summary
This is an open-label extension study for patients who participated in the BPS-MR-PAH-201 study.
Phase:
Phase 2
Details
Lead Sponsor:
Lung Biotechnology PBC
Treatments:
Beraprost
Epoprostenol